How Will Industry Counter Proposed Re-Pricing of “Huge Seller” Drugs?


Pricing premium for the promotion of new drug development and the elimination/resolution of off-label use:

The Column

No… Your Company Is Not like a Family!


Takeda Inks Deal with Nanotherapeutics to Expand Vaccine Technology Rights(Aug.28)
Chuikyo Rep Nakagawa Casts Doubt on 80% Generic Target(Aug.28)
MHLW Panel Recommends Creation of Database on Rare Cancers by Type(Aug.28)
MHLW Mulls Ordering Pfizer to Improve Biz Operations over ADR Reporting(Aug.28)
MTPC Chief Hints at No Major Merger, Plans Departure from Go-It-Alone Policy(Aug.28)

News Calendar